Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The sarcolemma in the Large(myd) mouse.

Patrick W Reed1, Katherine D Mathews, Kathleen A Mills

  • 1Department of Physiology, University of Maryland School of Medicine, 660 West Redwood Street, Baltimore, Maryland 21201, USA.

Muscle & Nerve
|September 25, 2004
PubMed
Summary

The Large(myd) mutation causes muscular dystrophy by altering sarcolemma composition and organization. Absence of the dystrophin complex destabilizes muscle, worsening the condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dysferlin's C2A domain supports normal Ca2+ signaling and membrane repair in dysferlin-null myofibers.

The Journal of general physiology·2026
Same author

Spatiotemporal DUX4 toxicity in FSHD: from epigenetic derepression to biomarker-driven targeted therapies.

Neuromuscular disorders : NMD·2026
Same author

Natural history of limb girdle muscular dystrophy R1 (LGMDR1): a GRASP consortium study.

Neuromuscular disorders : NMD·2026
Same author

Quantitative Measurement of Glycosylated ⍺-Dystroglycan as a Biomarker for Disease Severity in Limb-Girdle Muscular Dystrophy Type 2I/R9.

Neurology. Genetics·2026
Same author

Facioscapulohumeral muscular dystrophy diagnosed in childhood: a muscular dystrophy surveillance, tracking and research network cohort.

Neuromuscular disorders : NMD·2026
Same author

Predicting Loss of Ambulation in Limb Girdle Muscular Dystrophy R9.

Annals of clinical and translational neurology·2026

Area of Science:

  • Biochemistry
  • Cell Biology
  • Genetics

Background:

  • Muscular dystrophy in Large(myd) mice results from incomplete dystroglycan glycosylation, impairing ligand binding.
  • This defect leads to a severe form of muscular dystrophy, often fatal in young adulthood.

Purpose of the Study:

  • To investigate the structural and compositional changes in the sarcolemma of fast-twitch skeletal muscle fibers in Large(myd) mice.
  • To determine how the Large(myd) mutation affects the organization and localization of key sarcolemmal proteins.

Main Methods:

  • Analysis of sarcolemmal protein composition and organization in tibialis anterior and quadriceps muscles of Large(myd) mice and controls.
  • Immunohistochemical and biochemical techniques were employed to assess protein levels and distribution.

Related Experiment Videos

Main Results:

  • The Large(myd) mutation alters sarcolemma organization in fast-twitch skeletal muscle fibers.
  • Costameres show reduced levels of dystrophin and beta-spectrin.
  • Proteins of the dystrophin complex are absent from regions between costameres in Large(myd) muscles.

Conclusions:

  • The absence of the dystrophin complex from inter-costamere regions destabilizes the sarcolemma.
  • This destabilization contributes significantly to the severity of muscular dystrophy in Large(myd) mice.
  • Sarcolemmal protein positioning is critical for skeletal muscle health.